Kratos Defense & Security Solutions secured a $33.6 million contract to develop the power conversion system for NASA's Space Reactor-1 Freedom, the first nuclear fission reactor-powered spacecraft aimed for a 2028 Mars mission. This system will convert nuclear thermal energy into electricity to power the spacecraft's propulsion and operations, enabling efficient nuclear electric propulsion that reduces fuel needs and extends mission capabilities. The mission marks a significant step in space nuclear technology, supporting future deep space exploration and NASA's lunar base plans. Kratos' role highlights its growing presence in advanced space propulsion and national security technologies.
Kratos Defense & Security Solutions' contract for NASA's nuclear-powered spacecraft provides context for industrial sector activity. For readers following Industrials, here is Pluang's market snapshot as of Oct 28, 2026 18:01 WIB: out of 135 priced US stocks, 76 rose and 52 fell. Notable movers include MOD at USD 144.52 with a 1-day change of +5.87%, FPS at USD 28.54 with a 1-day change of +5.74%, and POWL at USD 168.92 with a 1-day change of +4.69%.
Circuit Mind secured $25 million in funding, including an $18.5 million Series A led by Norwest, to expand its AI platform that automates and optimizes electronic circuit board design. The platform helps companies reduce design time by up to 90%, cut...
Circuit Mind has introduced AVE (Agentic Verification Engine), an AI-powered application that verifies printed circuit board (PCB) schematics against datasheets and internal design rules to catch errors early and avoid expensive respins. AVE compleme...
Alvotech, a global biotech company specializing in biosimilars, will release its financial results for the first nine months of 2026 on November 11 after U.S. market close. A live webcast presentation is scheduled for November 12 at noon, where manag...
Sampo Oyj will publish its financial results for the first nine months of 2026 on November 4, 2026, at around 8:30 AM. Alongside the report, supplementary presentation materials will be available on their website. An investor conference call will be ...
Alvotech, a global biotech company specializing in biosimilars, announced it will report its financial results for the nine months and third quarter ending September 30, 2026, on November 11 after U.S. market close. The company will host a webcast wi...
